TERT and thyroid cancer, nonmedullary, 2: Furthermore, our study showed that there was no association between TERT promoter mutations and most aggressive clinicopathological characteristics in FTC, such as larger tumor size, male gender, vascular invasion, extrathyroidal extension, and LNM, which differed from the results of PTC.